Voya Investment Management LLC Biogen Inc. Transaction History

Voya Investment Management LLC

$86.1 Billion
Q1 2024

A detailed history of Voya Investment Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 98,088 shares of BIIB stock, worth $22.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

98,088

Previous 115,468 15.05%

Holding current value

$22.7 Million

Previous $29.9 Million 29.21%

% of portfolio

0.02%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $3.68 Million - $4.65 Million	-17,380 Reduced 15.05%	98,088 $21.2 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $471,668 - $567,764	2,119 Added 1.87%	115,468 $29.9 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $1 Million - $1.13 Million	-3,960 Reduced 3.38%	113,349 $29.1 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $856,302 - $989,484	-3,111 Reduced 2.58%	117,309 $33.4 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $456,676 - $520,365	1,780 Added 1.5%	120,420 $33.5 Million

Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $752,018 - $913,718	2,979 Added 2.58%	118,640 $32.9 Million
Q3 2022 Mar 03, 2023	SELL	$194.69 - $268.46 $579,981 - $799,742	-2,979 Reduced 2.51%	115,661 $30.9 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $11.3 Million - $15.6 Million	58,254 Added 101.48%	115,661 $30.9 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $1.93 Million - $2.29 Million	-10,283 Reduced 15.19%	57,407 $11.7 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $8.06 Million - $10.1 Million	-41,570 Reduced 38.05%	67,690 $14.3 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $6.66 Million - $8.56 Million	29,757 Added 37.43%	109,260 $26.2 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $3.5 Million - $4.56 Million	-12,364 Reduced 13.46%	79,503 $22.5 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $5.81 Million - $9.3 Million	-22,434 Reduced 19.63%	91,867 $31.8 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $1.29 Million - $1.51 Million	-5,314 Reduced 4.44%	114,301 $32 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $6.53 Million - $9.83 Million	-27,650 Reduced 18.78%	119,615 $29.3 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $2.45 Million - $2.83 Million	-9,265 Reduced 5.92%	147,265 $41.8 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $1.81 Million - $2.4 Million	-7,006 Reduced 4.28%	156,530 $41.9 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $6.66 Million - $8.45 Million	24,778 Added 17.86%	163,536 $51.7 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $485,672 - $671,082	-2,207 Reduced 1.57%	138,758 $41.2 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $784,740 - $880,162	-3,609 Reduced 2.5%	140,965 $32.8 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $152,625 - $168,237	-696 Reduced 0.48%	144,574 $33.8 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $176 Million - $276 Million	-813,189 Reduced 84.84%	145,270 $34.3 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $5.37 Million - $6.8 Million	19,291 Added 2.05%	958,459 $288 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $243 Million - $317 Million	826,232 Added 731.59%	939,168 $332 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $2.93 Million - $3.5 Million	-11,393 Reduced 9.16%	112,936 $32.8 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $98.3 Million - $139 Million	-377,897 Reduced 75.24%	124,329 $34 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $8.41 Million - $9.42 Million	27,339 Added 5.76%	502,226 $160 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $134 Million - $157 Million	474,887	474,887 $149 Million

Others Institutions Holding BIIB

# of Institutions

1,046

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Biogen Inc. Transaction History